Imbruvica 140 mg

Imbruvica 140 mg (Ibrutinib)

Active Ingredient Ibrutinib
Dosage Form Capsule
Available Strength 140mg
Manufacturer: Johnson & Johnson
Packaging 90 capsules in 1 bottle
Therapeutic use Mantle-cell lymphoma, Blood cancer (Chronic lymphocytic leukemia)
Pack Insert/Leaflet Yes
Production Capacity 1 Million Bottle's/Month

Description